Effects of Lipid Composition on the Properties of Doxorubicin-Loaded Liposomes

References

• Qiu L Jing N Jin Y . Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Int. J. Pharm.361, 56–63 (2008).
   PubMed Web of Science ®Google Scholar
• Malam Y Loizidou M Seifalian AM . Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci.30, 592–599 (2009).
   PubMed Web of Science ®Google Scholar
• Drummond DC Meyer O Hong K Kirpotin DB Papahadjopoulos D . Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev.51, 691–743 (1999).
   PubMed Web of Science ®Google Scholar
• Allen TM Chonn A . Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett.223, 42–46 (1987).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Hunter AC Murray JC . Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev.53, 283–318 (2001).
   PubMed Web of Science ®Google Scholar
• Tseng YC Mozumdar S Huang L . Lipid-based systemic delivery of siRNA. Adv. Drug Deliv. Rev.61, 721–731 (2009).
   PubMed Web of Science ®Google Scholar
• Sahay G Querbes W Alabi C et al. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol.31, 653–658 (2013).
   PubMed Web of Science ®Google Scholar
• Jiang W Lionberger R Yu LX . In vitro and in vivo characterizations of PEGylated liposomal doxorubicin. Bioanalysis3, 333–344 (2011).
   PubMed Web of Science ®Google Scholar
• Szebeni J Muggia F Gabizon A Barenholz Y . Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv. Drug Deliv. Rev.63, 1020–1030 (2011).
   PubMed Web of Science ®Google Scholar
• Ehmann F Sakai-Kato K Duncan R et al. Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines. Nanomedicine (Lond.)8, 849–856 (2013).
   PubMed Web of Science ®Google Scholar
• Xu X Khan MA Burgess DJ . A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. Int. J. Pharm.419, 52–59 (2011).
   PubMed Web of Science ®Google Scholar
• Rahman A Kessler A More N et al. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res.40, 1532–1537 (1980).
   PubMed Web of Science ®Google Scholar
• Gabizon A Dagan A Goren D Barenholz Y Fuks Z . Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res.42, 4734–4739 (1982).
   PubMed Web of Science ®Google Scholar
• Gabizon A Goren D Fuks Z Meshoren A Barenholz Y . Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model. Br. J. Cancer51, 681–689 (1985).
   PubMed Web of Science ®Google Scholar
• Storm G Roerdink FH Steerenbeg PA de Jong WH Crommelin DJ . Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res.47, 3366–3372 (1987).
   PubMed Web of Science ®Google Scholar
• Bangham AD Standish MM Watkins JC . Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol.13, 238–252 (1965).
   PubMed Web of Science ®Google Scholar
• Fritze A Hens F Kimpfler A Schubert R Peschka-Süss R . Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim. Biophys. Acta1758, 1633–1640 (2006).
   PubMed Web of Science ®Google Scholar
• Un K Sakai-Kato K Kawanishi T Okuda H Goda Y . Effects of liposomal phospholipids and lipid transport-related protein on the intracellular fate of encapsulated doxorubicin. Mol. Pharm.11, 560–567 (2014).
   PubMedGoogle Scholar
• Shehata T Ogawara K Higaki K Kimura T . Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int. J. Pharm.359, 272–279 (2008).
   PubMed Web of Science ®Google Scholar
• Sakai-Kato K Ishikura K Oshima Y et al. Evaluation of intracellular trafficking and clearance from HeLa cells of doxorubicin-bound block copolymers. Int. J. Pharm.423, 401–409 (2012).
   PubMedGoogle Scholar
• Mayer LD Bally MB Cullis PR . Strategies for optimizing liposomal doxorubicin. J. Liposome Res.1, 463–480 (1990).
   Google Scholar
• Papahadjopoulos D Watkins JC . Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. Biochim. Biophys. Acta135, 639–652 (1967).
   PubMed Web of Science ®Google Scholar
• Li Y Mitra AK . Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption. Pharm. Res.13, 76–79 (1996).
   PubMed Web of Science ®Google Scholar
• Felgner PL Ringold GM . Cationic liposome-mediated transfection. Nature337, 387–388 (1989).
   PubMed Web of Science ®Google Scholar
• da Cruz MT Simões S Pires PP Nir S de Lima MC . Kinetic analysis of the initial steps involved in lipoplex–cell interactions: effect of various factors that influence transfection activity. Biochim. Biophys. Acta1510, 136–151 (2001).
   PubMed Web of Science ®Google Scholar
• Lee RJ Wang S Turk MJ Low PS . The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery. Biosci. Rep.18, 69–78 (1998).
   PubMed Web of Science ®Google Scholar
• Un K Sakai-Kato K Goda Y . Intracellular trafficking mechanism of cationic phospholipids including cationic liposomes in HeLa cells. Pharmazie69, 525–531 (2014).
   PubMed Web of Science ®Google Scholar
• Xue HY Liu S Wong HL . Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond.)9, 295–312 (2014).
   PubMed Web of Science ®Google Scholar